| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/17/2004 | CN1481895A Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 03/17/2004 | CN1481894A Drug composition, its preparation method and use |
| 03/17/2004 | CN1481889A Water-purging pill comprising genkwanin and kansui root |
| 03/17/2004 | CN1481884A Skin-infiltrating film of Chinese traditional medicine for curing paralysis resulting from central nerve trauma and its preparation method |
| 03/17/2004 | CN1481882A Red peony root injection and its preparation method |
| 03/17/2004 | CN1481855A Yunan red drug tablet , its preparation method and use |
| 03/17/2004 | CN1481802A Tetracycline medication for prevention and cure of nerve trauma disease and deafness of infants |
| 03/17/2004 | CN1481798A Large capacity gingko damole injection and its preparation method |
| 03/17/2004 | CN1481787A Propylgallate injection and its preparing process |
| 03/16/2004 | US6706892 Adminstering maleimide derivative to covalently bond protein; wound healing, antibiotic, antiinflammatory, anticarcinogenic, hypotensive, and analgesic agents |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706745 Biphenylamidine derivatives |
| 03/16/2004 | US6706730 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706698 Anticholesterol agents |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2223745C Method of solubilizing, purifying, and refolding protein |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004019972A1 Use of erythopoietin |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019952A1 Use of prostacyclin and analogs thereof for improving venous flow |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004019758A2 Methods of treating idiopathic pulmonary fibrosis |
| 03/11/2004 | WO2004000219A3 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003033046A3 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 03/11/2004 | WO2003007873A3 Plasma protein matrices and methods for their preparation |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | WO2002070594A8 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 03/11/2004 | WO2002065987A3 Production of platelet rich plasma and autologous procoagulant |
| 03/11/2004 | WO2002058750A8 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/11/2004 | WO2002058749A8 Carrier with solid fibrinogen and solid thrombin |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040048906 Synergistic combinations of amlodipine and atorvastatin used to treat angina pectoris, atherosclerosis, combined hypertension and hyperlipidemia and to treat subjects with symptoms of cardiac risk |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/11/2004 | US20040048815 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/11/2004 | US20040048803 Treatment of thrombosis by administering a CD154 inhibitor, especially a metalloproteinase inhibitor. |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047903 For use in therapy of cancer |
| 03/11/2004 | US20040047895 Laver protein-containing composition and foods |
| 03/11/2004 | US20040047868 Administering probiotic, wherein the probiotic is probiotic bacteria selected from Lactobacillus species, with the proviso that the Lactobacillus species is not Lactobacillus GG for prophylaxis and therapy of endotoxemia |
| 03/11/2004 | US20040047862 Administering to mammal an effective amount of at least one monoclonal intravenous immunoglobulin (mIVIG) for a time and under conditions sufficient to increase the level of platelets |
| 03/11/2004 | DE10237442A1 Hochverzweigte, niedrig substituierte Stärkeprodukte Highly branched, low-substituted starch products |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496581A1 The use of erythopoieitin in the treatment of disturbances of iron distribution in diabetes |
| 03/11/2004 | CA2496314A1 Methods of treating idiopathic pulmonary fibrosis |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395610A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1200437B1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 03/10/2004 | CN1481387A Condensed purine derivatives as A1 adenosine receptor antagonists |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1480466A Interfusion protein possessing dual functions of thrombolysis and anticoagulation as well as its application |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480152A 聚甲酚磺醛喷雾剂 Policresulen sprays |
| 03/10/2004 | CN1480144A Compound preparation for treating and preventing thrombosis and apoplexia as well as its preparing method |
| 03/10/2004 | CN1480132A Protective solution for preventing local ischemic damage |
| 03/10/2004 | CN1141318C Human blood and blood vessel cytopoiesis hormone and its preparation |
| 03/10/2004 | CN1141141C Achyranthis bidentatae glycopeptide and its preparation |